Region: Global
Category: Life Sciences

Global Life Sciences

(45,011 reports matching your criteria)
  • EMS Products

    ... CAGR of 5.2% over the analysis period 2024-2030. Life Support & Emergency Resuscitation Systems, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$14.6 Billion by the ... Read More

  • Enterprise File Synchronization and Sharing (EFSS)

    ... reach US$77.7 Billion by 2030, growing at a CAGR of 24.6% over the analysis period 2024-2030. EFSS Solutions, one of the segments analyzed in the report, is expected to record a 21.7% CAGR and reach ... Read More

  • Environmental Sensors

    ... CAGR of 6.8% over the analysis period 2024-2030. Temperature Sensors, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$874.0 Million by the end of the analysis ... Read More

  • Examination Tables

    ... CAGR of 4.4% over the analysis period 2024-2030. General Examination Tables, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$372.2 Million by the end of the ... Read More

  • Eye Health Supplements

    ... at a CAGR of 4.9% over the analysis period 2024-2030. Tablet Form, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$1.2 Billion by the end of ... Read More

  • Food Allergen Testing

    ... at a CAGR of 3.6% over the analysis period 2024-2030. Peanut & Soy Source, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$1.1 Billion by the ... Read More

  • Fundus Cameras

    ... CAGR of 3.0% over the analysis period 2024-2030. Non-Mydriatic Fundus Cameras, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$204.8 Million by the end of the ... Read More

  • Healthcare Workforce Management Systems

    ... 2030, growing at a CAGR of 13.3% over the analysis period 2024-2030. Healthcare Workforce Management Systems Software, one of the segments analyzed in the report, is expected to record a 13.7% CAGR and reach US$4.4 ... Read More

  • Biocompatible Materials

    ... CAGR of 15.7% over the analysis period 2024-2030. Polymeric Materials, one of the segments analyzed in the report, is expected to record a 16.9% CAGR and reach US$231.0 Billion by the end of the analysis ... Read More

  • Chiral Technology

    ... CAGR of 3.6% over the analysis period 2024-2030. Intermediates, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$8.2 Billion by the end of the analysis period. ... Read More

  • Artificial Organs

    ... CAGR of 7.4% over the analysis period 2024-2030. Artificial Kidneys, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$23.1 Billion by the end of the analysis ... Read More

  • Active Data Warehousing

    ... at a CAGR of 9.7% over the analysis period 2024-2030. On-Premise Deployment, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$13.9 Billion by the end of ... Read More

  • Automotive Catalytic Converter

    ... at a CAGR of 6.3% over the analysis period 2024-2030. Three-Way Oxidation Reduction Catalytic Converter, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$12.9 Billion by ... Read More

  • Automotive Front End Module

    ... 2030, growing at a CAGR of 3.0% over the analysis period 2024-2030. Aluminum Material, one of the segments analyzed in the report, is expected to record a 3.0% CAGR and reach US$48.1 Billion by the ... Read More

  • Automotive Windshield

    ... CAGR of 5.2% over the analysis period 2024-2030. Laminated Glass Windshield, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$26.3 Billion by the end of the ... Read More

  • Beta Carotene

    ... CAGR of 4.8% over the analysis period 2024-2030. Natural Beta Carotene, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$459.0 Million by the end of the ... Read More

  • Biologics Safety Testing

    ... at a CAGR of 11.8% over the analysis period 2024-2030. Biologics Safety Testing Services, one of the segments analyzed in the report, is expected to record a 12.1% CAGR and reach US$5.5 Billion by the ... Read More

  • Biosurgery

    ... 4.1% over the analysis period 2024-2030. Bone Graft Substitutes, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$7.2 Billion by the end of the analysis period. ... Read More

  • Broadcast Equipment

    ... CAGR of 4.6% over the analysis period 2024-2030. Digital Broadcast Equipment, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$3.7 Billion by the end of the ... Read More

  • Buckwheat

    ... 4.6% over the analysis period 2024-2030. Buckwheat Groats, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$956.3 Million by the end of the analysis period. Growth ... Read More

  • Bulletproof Vests

    ... CAGR of 5.8% over the analysis period 2024-2030. Soft Vests, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$2.4 Billion by the end of the analysis ... Read More

  • Cardiovascular Information Systems

    ... at a CAGR of 6.0% over the analysis period 2024-2030. Web-based Cardiovascular Information Systems, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$1.4 Billion by the ... Read More

  • Cell Separation Technologies

    ... at a CAGR of 15.1% over the analysis period 2024-2030. Research Laboratories & Institutes End-Use, one of the segments analyzed in the report, is expected to record a 14.9% CAGR and reach US$24.9 Billion by ... Read More

  • Ceramic Membrane

    ... CAGR of 9.2% over the analysis period 2024-2030. Titania Material, one of the segments analyzed in the report, is expected to record a 10.2% CAGR and reach US$12.2 Billion by the end of the analysis ... Read More

  • Cerebrospinal Fluid (CSF) Management Devices

    ... Billion by 2030, growing at a CAGR of 3.6% over the analysis period 2024-2030. Shunts, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$1.5 Billion by ... Read More

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings